Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows.

Asia-Pacific: Five largest Mergers & Acquisitions deals by value in the Pharmaceuticals sector (LTM June 2022)

  • A total of 33 Mergers & Acquisitions (M&A) deals (pending and completed) were announced in the Pharmaceuticals of the Asia-Pacific region, in the last twelve months resulting in a total deal value of over $5,182.0 million. In the LTM period, January 2022 turned out to be the most prolific in terms of deal size, with a total deal value of $2,331.8 million, resulting in an average deal value of $1,165.9 million during that month. On the other hand, the month of November 2021 was the most prolific in terms of deal volume, recording a total of 8 deals, resulting in an average deal value of $104.0 million during that month.

  • Of the 33 deals, the deal secured between Samsung Biologics Co Ltd and Samsung Bioepis Co Ltd, was the largest M&A deal in the Asia-Pacific Pharmaceuticals sector, which was valued at $2,300.0 million and was completed on January 27, 2022. The second-largest deal was between Shanghai Fosun Pharmaceutical (Group) Co Ltd and Chengdu Antkin Biotechnology Co Ltd, while the third-largest deal was between PTT Public Co Ltd and Alvogen Emerging Markets Holdings Ltd. The Shanghai Fosun Pharmaceutical (Group) Co Ltd-Chengdu Antkin Biotechnology Co Ltd deal and the PTT Public Co Ltd-Alvogen Emerging Markets Holdings Ltd deal were valued at $627.3 million and $475.0 million, respectively. The fourth-largest deal was between Adams Aus Bidco Pty Ltd-1300SMILES Limited (Townsville) valued at $166.0 million, whereas the deal between Zhejiang Zuoli Pharmaceutical Co Ltd-Zhejiang Top Pharmaceutical Co Ltd valued at $156.9 million was the fifth-largest deal.

  • Cumulatively, the top five deals amounted to $3,725.2 million and accounted for nearly 71.89% of the total deals (by value) announced during the last twelve months. The Asia-Pacific region accounted for 4.15% of the total M&A deals done globally, and accounted for 11.11% of the total deal size on a global scale.

Asia-Pacific: Five largest Mergers & Acquisitions deals by value in the Pharmaceuticals sector (LTM June 2022)

Published: June 2022
Source: GlobalData

Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Visit Report Store
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward